Switch to:
Allergan PLC  (NYSE:AGN) Cash Flow from Discontinued Operations: $0 Mil (TTM As of Jun. 2017)

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Allergan PLC's cash flow from discontinued operations for the three months ended in Jun. 2017 was $0 Mil. It means Allergan PLC received $0 Mil from the sale of part of business quarterly. Allergan PLC's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2017 was $0 Mil.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Allergan PLC Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash Flow from Discontinued Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Allergan PLC Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cash Flow from Discontinued Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2017 was 0 (Sep. 2016 ) + 0 (Dec. 2016 ) + 0 (Mar. 2017 ) + 0 (Jun. 2017 ) = $0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Headlines

From the Internet

AGN
Imprimis Challenge Allergans Restasis Cheaper Product

- Seekingalpha 2017-10-20 02:58:18

AGN
Buy on Weakness: Cramer's 'Mad Money' Recap

- theStreet 2017-10-19 18:57:00

AGN
Allergan: All In or Fall Out?

- Barron's 2017-10-19 11:03:00

AGN
Company News For Oct 19, 2017

- Zacks 2017-10-19 09:04:00

AGN
Allergan Shares Verge Breakdown

- Seekingalpha 2017-10-19 08:41:15

AGN
J And J Unattractive

- Seekingalpha 2017-10-19 00:18:42

AGN
Generic Restasis Risk Metastasizes Shire

- Seekingalpha 2017-10-18 18:15:13

AGN
The Biggest Loser: Allergan’s Patent Troubles

- Barron's 2017-10-18 17:55:00

AGN
Is a Breakup Allergan's Best Bet?

- Barron's 2017-10-18 12:23:54

AGN
Is a Breakup Allergan’s Best Bet?

- Barron's 2017-10-18 10:10:00

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK